TIFA Human

TRAF-Interacting Protein with Forkhead-Associated Domain Human Recombinant
Cat. No.
BT24533
Source
Escherichia Coli.
Synonyms
TRAF-interacting protein with FHA domain-containing protein A, Putative MAPK-activating protein PM14, Putative NF-kappa-B-activating protein 20, TRAF2-binding protein, TIFA, T2BP, T6BP, TIFAA.
Appearance
Sterile Filtered clear solution.
Purity
Greater than 90.0% as determined by SDS-PAGE.
Usage
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. They may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

TIFA Human Recombinant produced in E.Coli is a single, non-glycosylated polypeptide chain containing 208 amino acids (1-184 a.a.) and having a molecular mass of 24kDa.
TIFA is fused to a 24 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
TIFA (TRAF-interacting protein with FHA domain-containing protein A) acts as an adapter protein that facilitates the interaction between IRAK1 and TRAF6 upon IL-1 stimulation. This interaction initiates downstream activation of the NF-kappa-B and AP-1 signaling pathways. TIFA plays a crucial role in the oligomerization and polyubiquitination of TRAF6, leading to the activation of TAK1 and IKK through a mechanism that does not rely on the proteasome.
Description
Recombinant Human TIFA, expressed in E.Coli, is a single, non-glycosylated polypeptide chain comprising 208 amino acids (specifically, amino acids 1 to 184). It possesses a molecular weight of 24kDa. To facilitate purification, a 24 amino acid His-tag is fused to the N-terminus of TIFA. The protein undergoes purification using proprietary chromatographic techniques.
Physical Appearance
A clear solution that has been sterilized through filtration.
Formulation
The TIFA protein is supplied in a solution with a concentration of 0.5mg/ml. The solution contains 20mM Tris-HCl buffer at a pH of 8.0, 20% glycerol, and 1mM DTT.
Stability
For short-term storage (up to 2-4 weeks), the product should be kept at a temperature of 4 degrees Celsius. For extended storage, it is recommended to freeze the product at -20 degrees Celsius. To ensure optimal stability during long-term storage, adding a carrier protein (such as 0.1% HSA or BSA) is advisable. It is important to avoid subjecting the product to repeated cycles of freezing and thawing.
Purity
The purity of the TIFA protein is determined to be greater than 90.0% based on SDS-PAGE analysis.
Synonyms
TRAF-interacting protein with FHA domain-containing protein A, Putative MAPK-activating protein PM14, Putative NF-kappa-B-activating protein 20, TRAF2-binding protein, TIFA, T2BP, T6BP, TIFAA.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMTSFED ADTEETVTCL QMTVYHPGQL QCGIFQSISF NREKLPSSEV VKFGRNSNIC HYTFQDKQVS RVQFSLQLFK KFNSSVLSFE IKNMSKKTNL IVDSRELGYL NKMDLPYRCM VRFGEYQFLM EKEDGESLEF FETQFILSPR SLLQENNWPP HRPIPEYGTY SLCSSQSSSP TEMDENES.

Product Science Overview

Introduction

TRAF-Interacting Protein with Forkhead-Associated Domain (TIFA) is a protein that plays a crucial role in the signaling pathways of the immune system. It is known for its interaction with Tumor Necrosis Factor Receptor-Associated Factors (TRAFs), particularly TRAF6, which is involved in the activation of NF-κB, a transcription factor that regulates the expression of various genes involved in immune and inflammatory responses .

Structure and Domain

TIFA contains a Forkhead-Associated (FHA) domain, which is a phosphopeptide-binding motif. This domain is essential for its function in signal transduction. The FHA domain allows TIFA to bind to phosphorylated serine or threonine residues on other proteins, facilitating the formation of protein complexes that are necessary for downstream signaling events .

Biological Functions

TIFA is involved in several biological processes, including:

  • NF-κB Activation: TIFA activates TRAF6, leading to the activation of NF-κB. This activation is crucial for the transcription of genes involved in immune responses .
  • DNA Damage Response: TIFA transduces DNA damage-induced activation of NF-κB. It accumulates on damaged chromatin following genotoxic stress and enhances the transcription of NF-κB target genes, such as IL-6 and IL-8 .
  • Cell Cycle Regulation: TIFA has been shown to inhibit entry into the S phase of the cell cycle, suggesting a role in cell cycle regulation .
Preparation Methods

Human recombinant TIFA can be produced using recombinant DNA technology. The gene encoding TIFA is cloned into an expression vector, which is then introduced into a suitable host cell, such as E. coli or mammalian cells. The host cells express the TIFA protein, which can be purified using various chromatographic techniques.

Regulatory Mechanisms

TIFA’s activity is regulated through phosphorylation. Phosphorylation at specific threonine residues is crucial for its function in DNA damage response and NF-κB activation. Additionally, TIFA interacts with TRAF2, an E3 ubiquitin ligase, to mediate the ubiquitination of NF-κB essential modulator (NEMO), further regulating NF-κB signaling .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.